Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Non-invasive Dermatologic Procedure With XP200 Radiofrequency for the Primary Treatment of Wrinkles and Rhytids

NCT01795417 is registered in ClinicalTrials.gov with BTL Industries Ltd. as lead sponsor.

NCT NCT01795417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01795417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Non-invasive Dermatologic Procedure With XP200 Radiofrequency for the Primary Treatment of Wrinkles and Rhytids
Lead sponsor
BTL Industries Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2012
Completion date
March 31, 2013
Enrollment
50 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

periorbital wrinkles